Literature DB >> 3153468

Glucocorticoid regulation of transcription of the c-myc cellular protooncogene in P1798 cells.

A M Forsthoefel1, E A Thompson.   

Abstract

Glucocorticoids regulate proliferation of lymphosarcoma P1798 in culture. Treatment with dexamethasone caused a redistribution of cells with respect to the cell cycle. A decrease in cells in S and G2 + M phases was observed. This was accompanied by a corresponding increase in G1 cells. Growth arrest was preceded by a rapid and precipitous decrease in the expression of the cellular c-myc gene. Restriction analysis of the c-myc gene indicated that this locus was neither amplified nor grossly rearranged in P1798 cells. Glucocorticoids caused a decrease in the abundance of c-myc mRNA. After 24 h in 0.1 microM dexamethasone, c-myc mRNA levels declined to less than 5% of control. Fifty percent inhibition occurred within 90 min. The effects of dexamethasone were completely reversible. The amount of c-myc mRNA returned to control levels within 4 h after withdrawal of the hormone. Nuclear run-on transcription analysis indicated that glucocorticoids regulate transcription of the c-myc gene in P1798 cells. Transcription of exons I and II was inhibited to the same extent, suggesting that glucocorticoids inhibit initiation of transcription. Inhibition of transcription may account for decreased expression of c-myc which may, in turn, account for the antiproliferative effects of the hormone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3153468     DOI: 10.1210/mend-1-12-899

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  8 in total

1.  Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.

Authors:  M Maroder; S Martinotti; A Vacca; I Screpanti; E Petrangeli; L Frati; A Gulino
Journal:  Nucleic Acids Res       Date:  1990-03-11       Impact factor: 16.971

2.  Glucocorticoid mediated transcriptional repression of c-myc in apoptotic human leukemic CEM cells.

Authors:  F Zhou; R D Medh; E B Thompson
Journal:  J Steroid Biochem Mol Biol       Date:  2000 Jul-Aug       Impact factor: 4.292

3.  Rapid induction of the c-jun protooncogene in the avian oviduct by the antiestrogen tamoxifen.

Authors:  C K Lau; M Subramaniam; K Rasmussen; T C Spelsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

4.  Involvement of c-myc in the resistance of non-obese diabetic mice to glucocorticoid-induced apoptosis.

Authors:  T C Martins; A P Aguas
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

Review 5.  Glucocorticoids in T cell apoptosis and function.

Authors:  M J Herold; K G McPherson; H M Reichardt
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

6.  Glucocorticoid inhibition of 235-1 rat pituitary tumor cell cycle progression.

Authors:  Beverly C Delidow; Miranda Wang; Sonita V Bhamidipaty; Lynn D Black
Journal:  Endocrine       Date:  2002-03       Impact factor: 3.925

7.  Hepatocarcinogenic potential of the glucocorticoid antagonist RU486 in B6C3F1 mice: effect on apoptosis, expression of oncogenes and the tumor suppressor gene p53.

Authors:  Jihan A Youssef; Mostafa Z Badr
Journal:  Mol Cancer       Date:  2003-01-03       Impact factor: 27.401

8.  Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone.

Authors:  D A Wolf; F Kohlhuber; P Schulz; F Fittler; D Eick
Journal:  Br J Cancer       Date:  1992-03       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.